Kenneth K Tong

age ~73

from Claremont, CA

Get Report

Also known as:

Connected to:

Treatment Of Autoimmune Disorder With A Neurotoxin
view source
US Patent:

20060286127, Dec 21, 2006
Filed:

Jun 17, 2005
Appl. No.:

11/156502
Inventors:

Pamela Van Schaack - Costa Mesa CA, US
Kenneth Tong - Carlsbad CA, US
Assignee:

Allergan, Inc. - Irvine CA
International Classification:

A61K 39/08
US Classification:

424239100
Abstract:

Methods of treating one or more autoimmune disorders include a step of administering a Clostridial neurotoxin, such as a botulinum toxin, to a patient that has an autoimmune disorder. In one aspect, a method includes a step of administering the neurotoxin to the thymus gland or near the thymus gland of the patient. In another aspect, a method includes a step of administering the neurotoxin in combination with administering a cytokine inhibitor to the patient. Compositions are also described.

Treatment Of Autoimmune Disorders With A Neurotoxin
view source
US Patent:

20120093827, Apr 19, 2012
Filed:

Dec 20, 2011
Appl. No.:

13/332239
Inventors:

Pamela D. Van Schaack - Costa Mesa CA, US
Kenneth L. Tong - Carlsbad CA, US
Assignee:

ALLERGAN, INC. - Irvine CA
International Classification:

A61K 39/08
A61P 37/00
A61K 39/395
US Classification:

4241451, 4242391
Abstract:

Methods of treating one or more autoimmune disorders include a step of administering a Clostridial neurotoxin, such as a toxin, to a patient that has an autoimmune disorder. In one aspect, a method includes a step of administering the neurotoxin to the thymus gland or near the thymus gland of the patient. In another aspect, a method includes a step of administering the neurotoxin in combination with administering a cytokine inhibitor to the patient. Compositions are also described.